GABAergic regulation of cerebellar NG2 cell development is altered in perinatal white matter injury M Zonouzi, J Scafidi, P Li, B McEllin, J Edwards, JL Dupree, L Harvey, ... Nature Neuroscience 18 (5), 674-682, 2015 | 191 | 2015 |
Endothelial Dysfunction in Pulmonary Arterial Hypertension: An Evolving Landscape (2017 Grover Conference Series) B Ranchoux, LD Harvey, RJ Ayon, A Babicheva, S Bonnet, SY Chan, ... Pulmonary circulation, 2045893217752912, 2017 | 144 | 2017 |
Administration of DHA reduces endoplasmic reticulum stress-associated inflammation and alters microglial or macrophage activation in traumatic brain injury LD Harvey, Y Yin, IY Attarwala, G Begum, J Deng, HQ Yan, CE Dixon, ... ASN Neuro 7 (6), 1759091415618969, 2015 | 99 | 2015 |
ER stress and effects of DHA as an ER stress inhibitor G Begum, L Harvey, CE Dixon, D Sun Translational Stroke Research 4 (6), 635-642, 2013 | 63 | 2013 |
Emerging Metabolic Therapies in Pulmonary Arterial Hypertension LD Harvey, SY Chan Journal of Clinical Medicine 6 (4), 43, 2017 | 48 | 2017 |
Simultaneous Pharmacologic Inhibition of Yes‐Associated Protein 1 and Glutaminase 1 via Inhaled Poly (Lactic‐co‐Glycolic) Acid–Encapsulated Microparticles Improves Pulmonary … AP Acharya, Y Tang, T Bertero, YY Tai, LD Harvey, CSC Woodcock, ... Journal of the American Heart Association 10 (12), e019091, 2021 | 15 | 2021 |
Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells CSC Woodcock, N Hafeez, A Handen, Y Tang, LD Harvey, LE Estephan, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 320 (5 …, 2021 | 15 | 2021 |
YAPping about glutaminolysis in hepatic fibrosis LD Harvey, SY Chan Gastroenterology 154 (5), 1231-1233, 2018 | 6 | 2018 |
Evolving systems biology approaches to understanding non‐coding RNAs in pulmonary hypertension LD Harvey, SY Chan The Journal of Physiology 597 (4), 1199-1208, 2019 | 5 | 2019 |
Genetic regulation and targeted reversal of lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension LD Harvey, M Alotaibi, HJJ Kim, YY Tai, Y Tang, W Sun, W El Khoury, ... bioRxiv, 2024.02. 26.582142, 2024 | 1 | 2024 |
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function MK Culley, RJ Rao, M Mehta, J Zhao, W El Khoury, LD Harvey, D Perk, ... Vascular Pharmacology 151, 107181, 2023 | 1 | 2023 |
GENETIC CONTROL OF LYSOSOMAL DYSFUNCTION REPROGRAMS INFLAMMATORY STEROL METABOLISM IN PULMONARY ARTERIAL HYPERTENSION LD Harvey, HJ Kim, W Sun, W El Khoury, C St Croix, JY Lee, M Pauciulo, ... Journal of the American College of Cardiology 83 (13_Supplement), 4600-4600, 2024 | | 2024 |
Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in pulmonary arterial hypertension M Alotaibi, LD Harvey, W Nichols, MW Pauciulo, AR Hemnes, T Long, ... bioRxiv, 2024.01. 20.576474, 2024 | | 2024 |
Genetic and Acquired DHCR7 Deficiency Upregulates 7β-hydroxycholesterol to Drive Endothelial Apoptosis and Pulmonary Hypertension RJ Rao, HJ Kim, S Jiang, YY Tai, B Wang, Y Tang, W El Khoury, ... Circulation 148 (Suppl_1), A17196-A17196, 2023 | | 2023 |
Therapeutic and diagnostic target for SARS-CoV-2 and COVID-19 SY Chan, LLD Harvey US Patent 11,773,391, 2023 | | 2023 |
Genetic Control of Lysosomal Dysfunction Reprograms Sterol Metabolism in Pulmonary Arterial Hypertension LD Harvey, HJJ Kim, M Alotaibi, YY Tai, Y Tang, S Arshad, W Sun, H Wu, ... Circulation 146 (Suppl_1), A10096-A10096, 2022 | | 2022 |
NCOA7 Deficiency Reprograms Lysosomal Behavior and Sterol Metabolism to Promote Endothelial Dysfunction and Pulmonary Arterial Hypertension LD Harvey University of Pittsburgh, 2021 | | 2021 |
The Role of EBP50 in Regulating Endothelial-To-Mesenchymal Transition in Pulmonary Hypertension A Gorelova University of Pittsburgh, 2020 | | 2020 |